260
Participants
Start Date
May 31, 2016
Primary Completion Date
January 22, 2018
Study Completion Date
January 22, 2018
Estetrol
All treatments (E4 \[2.5 mg, 5 mg, 10 mg, 15 mg\] capsule) will be administered once daily (QD) per os for at least 12 consecutive weeks until the last biological assessments (Day 90 maximum) have been performed.
Placebo
1 capsule will be administered QD per os for at least 12 consecutive weeks until the last biological assessments (Day 90 maximum) have been performed.
Donesta Bioscience BV, Liège
Lead Sponsor
Collaborators (1)
SynteractHCR
INDUSTRY
Donesta Bioscience
INDUSTRY